Astrazeneca (AZN) Stock Analysis: AI Score & Alternative Data
AZN alt-data: revenue climbing, Reddit mentions lagging
Is Astrazeneca a buy right now? The alternative data says hold. This AZN stock analysis is built on the 25+ alternative data signals AltIndex tracks on Astrazeneca every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 50/100: a Hold. The stock trades at $156.45 with a $243B market cap.
The bullish side of the 90-day ledger: revenue up 6.4% YoY to $15.4B, web traffic up 10.3% to 1.2M monthly visits, and 79% of employees are positive on the business outlook. The drag: Reddit mentions down 50.0% to 1 a day. That tension is what keeps the score mid-range.
AZN’s broader alt-data profile also covers job postings (1,007 open roles), headcount (82K employees, according to LinkedIn), X followers (292K), and sentiment (100/100). Every signal links to its own page with full history, the AZN technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on AZN is just below.
Astrazeneca AI Stock Analysis
AstraZeneca is a global, science-led biopharmaceutical business whose innovative medicines are used by millions of patients worldwide. The company focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in areas such as oncology, cardiovascular, renal & metabolism, and respiratory & immunology.
Analysis generated August 2, 2026.
Recent Astrazeneca Stock Alerts
|
Astrazeneca | August 3 Price is down by -7.4% in the last 24h. |
|
Astrazeneca | July 9 Price is down by -8.3% in the last 24h. |
|
Astrazeneca | July 2 Price is up by 6.4% in the last 24h. |
|
Astrazeneca | June 8 Job postings are up by 30.1% in the last couple of days. |
Astrazeneca Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 1.2M | 10.3% | |
| Job Posts | 1K | 0.7% | |
| LinkedIn Employees | 82K | 3.3% | |
| Wikipedia Views | 488 | 4.9% | |
| Employee Recommend | 79 | 0% | |
| Business Outlook | 79 | 0% | |
| Lobbying Cost | $263K | 0% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 1 | 50.0% | |
| X Mentions | 4 | 300.0% | |
| Stocktwits Mentions | 19 | 5.0% | |
| News Mentions | 4 | 69.2% | |
| Stocktwits Subscribers | 19K | 1.1% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 292K | 0% | |
| Instagram Followers | 103K | 1.8% | |
| Youtube Subscribers | 20K | 1.5% | |
| Facebook Followers | 78K | 1.0% | |
| Facebook Engagement | 135 | 5.6% |
About Astrazeneca (AZN)
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.
| Price | $156.45 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $243B |
| Year Range | $143 – $207 |
| Dividend Yield | 0% |
| PE Ratio | 23.5 |
| Analyst Rating | 38% buy |
| Industry | Drug Manufacturers |
Latest Astrazeneca News
View more →
Hedge Funds are Bullish on AstraZeneca PLC (AZN)August 11 - Yahoo Entertainment |
|
 |
Astrazeneca Pharma India standalone net profit declines 32.06% in the June 2026 quarterAugust 10 - Business Standard |
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZNAugust 4 - GlobeNewswire |
|
Astrazeneca Q2 Earnings Call HighlightsJuly 27 - MarketBeat |
|
Astrazeneca Earnings & Financial Performance
View all earnings →Astrazeneca Insider Trading Activity
View all →| Sharma Mani filed to sell 19,262 shares at $0.0. May 20 '26 |
Astrazeneca Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julia Letlow |
Jan 14, 26 | Buy | $8K+ |
| Gilbert Cisneros |
Jan 13, 26 | Buy | $8K+ |
| Gilbert Cisneros |
Dec 16, 25 | Buy | $8K+ |
| Lisa McClain |
Nov 24, 25 | Sell | $8K+ |
| Lisa McClain |
Nov 24, 25 | Sell | $8K+ |
Stocks Similar to Astrazeneca
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Novo NordiskNVO |
$45.89 1.8% | $201B | 53 |
 |
PfizerPFE |
$26.79 0.0% | $153B | 42 |
 |
Merck & CompanyMRK |
$135.84 0.2% | $335B | 57 |
 |
Bristol-Myers SquibbBMY |
$63.83 1.3% | $130B | 55 |
 |
SanofiSNY |
$43.72 0.1% | $105B | 49 |
Explore Astrazeneca Data
Frequently Asked Questions: Astrazeneca (AZN)
Astrazeneca has an AltIndex AI Score of 50/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
50/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Astrazeneca (AZN) stock is $156.45 with a market cap of $243B.
As of today, Astrazeneca’s PE (Price to Earnings) ratio is 23.5.
View the latest Astrazeneca insider transactions to see recent buying and selling activity by company executives and directors.
Check the Astrazeneca congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The AZN stock price chart above shows Astrazeneca’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Astrazeneca technical analysis for RSI, moving averages, and more.
See the stocks similar to Astrazeneca section on this page for companies in the same industry ranked by market cap and AI Score.
